Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Linagliptin 5 mg tablet in healthy Thai participants under fasting
TCTR20260607002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of linagliptin (2 arms), sponsored by Bio-innova. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
linagliptin
Beyond the preview
Go deeper on TCTR20260607002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260607002.